(Q44512657)

3 December 2017

title

Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats (English)

1 reference

3 December 2017

1 reference

Shaifali Bhalla

1

1 reference

3 December 2017

George Matwyshyn

series ordinal

2

1 reference

3 December 2017

Anil Gulati

series ordinal

3

1 reference

3 December 2017

publication date

1 April 2003

1 reference

3 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Peptides

1 reference

3 December 2017

volume

24

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

553-561

1 reference

Role of morphine maintenance dose in the development of tolerance and its attenuation by an NMDA receptor antagonist

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Potentiation of morphine analgesia by BQ123, an endothelin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Neurobiological mechanisms of opioid tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Characterization of a coronary vasoconstrictor produced by cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Comparative Distribution of Neurons Containing FLFQPQRFamide-like (morphine-modulating) Peptide and Related Neuropeptides in the Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Modification of systemic and regional circulatory effects of intracerebroventricular administration of endothelin-1 by propranolol in anesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Regulations of opioid dependence by opioid receptor types

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

The Abstinence Syndrome in Long‐Term, High‐Dosage Narcotic Addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

New therapeutics that antagonize endothelin: promises and frustrations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Phorbol ester dissociates endothelin-stimulated phosphoinositide hydrolysis and arachidonic acid release in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

A review of the role of anti-opioid peptides in morphine tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Endogenous opiates: 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Endogenous opiates: 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

Cellular and synaptic adaptations mediating opioid dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900110-4

7 January 2021

10.1016/S0196-9781(03)00110-4

Identifiers

DOI

1 reference

3 December 2017

1 reference